Cloning and expression of toxoplasma antigens and use of recombinant antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5578453
SERIAL NO

07972481

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A synthetic or recombinant polypeptide displaying the antigenicity of all or an antigenic fragment of the H4 or H11 polypeptides of Toxoplasma gondii, and recombinant DNA molecules, vectors and host cells for the expression thereof. Use of the polypeptide in vaccine compositions and in diagnostic immunoassays is also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FLINDERS UNIVERSITY OF SOUTH AUSTRALIA THESTURT ROAD BEDFORD PARK SOUTH AUSTRALIA 5042

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johnson, Alan M East Roseville, AU 7 73
McDonald, Peter J Belair, AU 5 23

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation